Guy Levy

Guy Levy (board member) discloses dealings in BioAtla, Inc. to SEC (Form 4). Between 18 December 2020 and 30 September 2021, the trades on record add up to 9 filings.

The open-market side counts 2 purchases for €20.4M alongside 5 sales for €31.6M. Sales outweigh purchases by €11.2M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 1 share grant. Since January 2021: no purchases and 5 sales on the market.

Most recently, on 30 September 2021, the filings show a share grant in BioAtla, Inc. The most recent open-market purchase was published on 22 December 2020, 2,148 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.